Article Details
Retrieved on: 2023-10-30 15:30:50
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CHICAGO, October 30, 2023--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here